16 results
Stroke Rate by CHADS2 Score (Gage et al., JAMA, 2001) https://www.ncbi.nlm.nih.gov/pubmed/?term=11401607 #EBM #EM #IM #Cardiology #CHADS2
term=11401607 #EBM ... #EM #IM #Cardiology ... Score #StrokeRate #ALiEM
Long-Term PEITHO Results #EBM #EM #IM #PCC #PEITHO #PE #PulmonaryEmbolism #Embolism #RebelEM
Long-Term PEITHO ... Results #EBM #EM ... #IM #PCC #PEITHO
Petechiae are small, red lesions caused when capillaries leak blood into the skin. Petechiae larger than
purpura #Clinical #EM ... #IM #Derm #Petechiae
Centor - Clinical Decision Rule for Management of Sore Throat #Diagnosis #Management #EM #IM #Centor #Criteria
Centor - Clinical ... Diagnosis #Management #EM ... #IM #Centor #Criteria ... #StrepThroat #Algorithm
Causes of Syncope #Diagnosis #EM #IM #Neuro #Syncope #Differential #Algorithm #Ddxof
Syncope #Diagnosis #EM ... #IM #Neuro #Syncope ... #Differential #Algorithm
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Treatment of Chronic Migraine ... Secondary End Points #EBM ... #Neuro #IM #Fremanezumab ... #Migraine #CGRP ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Treatment of Chronic Migraine ... Secondary End Points #EBM ... #Neuro #IM #Fremanezumab ... #Migraine #CGRP ... CalcitoninGeneRelatedPeptideAntibody #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Adverse Events in the Safety Population, According
to Trial Group #EBM ... #Neuro #IM #Fremanezumab ... #Migraine #CGRP ... AdverseEvents #NEJM ... #NEJM
Centor - Clinical Decision Rule for Management of Sore Throat #Diagnosis #Management #EM #IM #Centor #Criteria
Centor - Clinical ... Diagnosis #Management #EM ... #IM #Centor #Criteria ... #StrepThroat #Algorithm
Nikolsky’s Sign - Febrile & Positive Nikolsky’s Sign: Patients in this group have the potential to
#Clinical #EM #IM ... #Derm #Nikolsky